New medicine for orphan and Rare diseases has the capability to undoubtedly impact the lives of patients, where historically there were few or no treatments have been provided to control the sickness. The Orphan Drug Act (ODA) established in 1983 compelled producers to expand scale to treat uncommon/orphan diseases, and the orphan drug panorama has advanced drastically. Approvals for orphan drugs has doubled in the past decade, and there are over 500 applicants in the pipeline for orphan diseases.

MarketsandMarkets Digital Event on Orphan Drugs and Rare Diseases scheduled to be held on 9th -10th July 2020 will provide valuable and necessary platform for uplifting knowledge at the forefront of drug analysis. Over the course of the conference, internationally-renowned speakers can describe how their analysis journeys have developed the response towards up to date challenges. The attending specialists and trade partners will offer an incredible networking expertise.

 

Harnessing data has become integral to any organization’s growth and development. The continuous evolution of Big Data technology has led to the growing use of AI, ML and cloud architecture. With newer trends emerging, it is essential to keep track of these and incorporate them into our data strategy. The Global Pandemic has also caused tech giants to invest in collecting, analysing and strategizing on transforming their businesses through digitization. To leverage the opportunities and address industry challenges, the masterclass focuses on building efficient data strategies, accelerating business values through data-driven transformation, developing a stable cloud computing architecture, using AI and ML effectively and overcoming data management challenges during COVID-19.

What is the future of technology in the Automotive industry? Automotive companies are embracing connected and smart technologies to offer safer and future-ready vehicles by investing in Advanced Driver Assistance Systems (ADAS). The battleground to win the customers is one of the driving forces for automotive manufacturers and OEMs to adopt the technology and lead the marketplace. However, the safety concerns and regulations around autonomous vehicles, communications systems, etc are limiting the acceptance of the technology.

The Biosimilars industry is experiencing significant growth due to the rising incidence of chronic diseases and the increasing demand for biosimilars due to their cost-effectiveness.

The global biosimilars market size is expected to grow from USD 35.7 billion by 2025 from USD 11.8 billion in 2020, at a CAGR of 24.7%. However, with complexities in manufacturing and resistance from biologic manufacturers, such factors keeps adding to the hinderance in their development.

HR is one of the key entities of all organization and technology disruption is the primary focus for professional development. HR leaders must develop the capacity to transform, support business goals and build the workforce of the future.

MarketsandMarkets Chief HR Tech Virtual Summit on 13-14 August 2020 is bringing together chief HR Tech influencers and leaders from a wide range of industries to access the latest HR tech insights and transformation success strategies required to embrace change in 2020 and beyond. The conference is focusing on synergy between technology and human resources to strike for remarkable business results. 

The cytotoxic nature of HPAPIs presents significant handling challenges and thus requires heavy investments for implementing specialized containment facilities that facilitate the safety of employees from exposure. Owing to their target release characteristics, HPAPIs find major applications in target therapies for cancer. 

One of the major challenges faced by the players in this market, especially CMOs that offer HPAPI manufacturing services, is the continual evolution of industry standards, technologies, and regulations. 

MarketsandMarkets is proud to announce the 4th Annual High Potent Medicines Conference to be held on 14th - 15th September 2020 . This conference would address the challenges in the continual evolution of industry standards, technologies, and regulations. Leading experts from the industry will discuss the strategies for both in-house manufacturing and outsourcing by presenting expert keynote presentations, live case studies and breakthrough panel discussions.

Industrial revolution influences mission-critical applications in business processes and the manufacturing companies that take the risk and are early adopters of new technology will be rewarded for their progressive decision-making. Since, digitization helps to ensure product quality and safety, as well as faster service delivery, which goes a long way with customers. This has made the revolution the need of the hour!

The successful inaugural event of MarketsandMarkets Industry 4.0 Conference-Chicago, focused on the impact of IIOT and Cybersecurity, by addressing a series of application-based illustrations and discussions to map the future possibility of trends in the manufacturing world.

Technology, digitization, and globalization are disrupting conventional business models. The design and customer experience functions are witnessing an exponential shift. In today’s rapidly evolving world, it is essential to connect with customers to stay ahead and gain a competitive advantage. Design Thinking helps organizations to understand the people for whom they are designing their products or services. Design Thinking enables the integration of technology with a human-centered approach into the business strategy.

Point-of-care testing (POCT) is a growing technology. Today, you may see POCT in a hospital with hand held gadgets or small testers in emergency department, extensive care setting, popular clinical wards and imaging facilities. And market analyses that the world is moving from critical laboratory testing to testing for quick and accurate results at the patient's point of care.

As per MarketsandMarkets research analysis, the global dPCR and qPCR is estimated to grow to USD 6,270.9 million by 2024 at a CAGR of 8.8%. Factors such as the rising incidences of target infectious diseases and genetic disorders; continuous technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs—especially that of dPCR—and the technical limitations of PCR have restricted their greater use.

While the viruses play a major role in molecular and cell biology to epidemiology, immunobiology and medical research, it has now become more crucial due to the global pandemic effect. 

The revelation of immunization has prompted the near eradication of several disease and has tremendously affected wellbeing and health.

Ongoing advances in vaccine innovation coming from the application of genetic engineering like mRNA & DNA are now providing an opportunity to target new diseases.

However, even with novel platforms, COVID-19 vaccine development poses challenges. Debate continues over the best methodology — for instance, targeting the full-length protein or just the receptor-binding domain.

MarketsandMarkets is proud to announce the 3rd Annual Real-World Data, Life Sciences Analytics and Market Access – Virtual Conference to be held on October 22nd -23rd, 2020.

While the 2nd annual Congress had discussions on accelerating the adoption of Real-world Evidence within the industry while understanding the capabilities of newer technologies for evidence generation, the 3rd Annual will focus on how the insights derived from real world data, as well as acknowledgment of the effect the insights can have on improving decision making and patient consideration both internally and by regulators, doctors, and payers.